-
Senju Pharmaceutical Co. Ltd. et al v. Lupin Limited et al DC CAFC
- 1:11-cv-00271
- D. Del.
- Judge: Sue L. Robinson
+1
- Filed: 03/31/2011
- Closed: 08/09/2013
- Latest Docket Entry: 05/12/2015
- PACER
3
Plaintiffs
3
Defendants
1
Accused
Product
2
Patents-in-Suit
863
Days in
Litigation
-
Senju Pharmaceutical Co. Ltd. et al v. Lupin Limited et al DC CAFC
- 1:11-cv-00271
- D. Del.
- Judge: Sue L. Robinson
+1
- Filed: 03/31/2011
- Closed: 08/09/2013
- Latest Docket Entry: 05/12/2015
- PACER
Causes of Action
Infringement
Willful Patent Infringement
Assigned Judge
Outcome Summary
Patent Information
-
Validity & Enforceability
| Claim # | Claim Text | Outcome |
|---|---|---|
| 6 |
A method for raising corneal permeability of Gatifloxacin which comprises incorporating disodium edetate into eye drops containing Gatifloxacin or its salt.
|
Invalid (103)
Entry 192 |
-
Infringement
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Gatifloxacin ophthalmic solutionGatifloxacin ophthalmic solution 0.3%, Gatifloxacin ophthalmic solution 0.5%Gatifloxacin sesquihydrateGeneric ZymarGeneric Zymaxid | US 6,333,045 B1 |
6
|
No infringement
Entry 192
|
Lupin Limited
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Gatifloxacin ophthalmic solutionGatifloxacin ophthalmic solution 0.3%, Gatifloxacin ophthalmic solution 0.5%Gatifloxacin sesquihydrateGeneric ZymarGeneric Zymaxid | US 6,333,045 B1 |
6
|
No infringement
Entry 192
|
Lupin Pharmaceuticals Incorporated
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Gatifloxacin ophthalmic solutionGatifloxacin ophthalmic solution 0.3%, Gatifloxacin ophthalmic solution 0.5%Gatifloxacin sesquihydrateGeneric ZymarGeneric Zymaxid | US 6,333,045 B1 |
6
|
No infringement
Entry 192
|